Increased RUNX1 mutations in breast cancer disease progression.

Abstract excerpt

Despite advances in screening, therapy and surveillance, breast cancer remains threatening to women. Worst, patients suffer from side effects of treatments and cancer cells become resistant. The emergence of RUNX1 in breast cancer has put it in a spotlight due to its roles in the disease progression. It also plays important roles in normal mammary glands such as for cell growth, proliferation, migration and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aged
• Share to Breast Neoplasms
• Share to Core Binding Factor Alpha 2 Subunit